Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 4, 2006, Pages 904-908

  Levi, Marcel ^a   Choi, Goda ^a   Picavet, Charles ^b   Hack, C Erik ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b The Netherlands Patient Association of Hereditary Angio edema and Quincke's Edema   (Netherlands)

Author keywords

acquired angioedema; C1 inhibitor concentrate; C1 inhibitor deficiency; hereditary angioedema

Indexed keywords

CETOR; COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; INJECTION SITE REACTION; MALE; PAIN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN DEFICIENCY; SELF INJECTION; SKIN IRRITATION; SYMPTOM;

ADULT; ANGIONEUROTIC EDEMA; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT EDUCATION; SAFETY; SELF ADMINISTRATION;

EID: 33646022921     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.002     Document Type: Article

References (18)

1. Agostoni A., and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 71 (1992) 206-215
2. Cicardi M., Bergamaschini L., Cugno M., Beretta A., Zingale L.C., Colombo M., et al. Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology 199 (1998) 366-376
3. Davis III A.E. The pathophysiology of hereditary angioedema. Clin Immunol 114 (2005) 3-9
4. Kaplan A.P. C1 inhibitor deficiency: hereditary and acquired forms. J Investig Allergol Clin Immunol 11 (2001) 211-219
5. Gelfand J.A., Sherins R.J., Alling D.W., and Frank M.M. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 295 (1976) 1444-1448
6. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 suppl (2004) S51-S131
7. Bork K., and Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol 36 (2002) 707-709
8. Szeplaki G., Varga L., Valentin S., Kleiber M., Karadi I., Romics L., et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 115 (2005) 864-869
9. Frank M.M., Sergent J.S., Kane M.A., and Alling D.W. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 286 (1972) 808-812
10. Cugno M., Cicardi M., and Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol 93 (1994) 870-876
11. Gadek J.E., Hosea S.W., Gelfand J.A., Santaella M., Wickerhauser M., Triantaphyllopoulos D.C., et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 302 (1980) 542-546
12. Waytes A.T., Rosen F.S., and Frank M.M. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 334 (1996) 1630-1634
13. Bork K., and Barnstedt S.E. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 161 (2001) 714-718
14. Kunschak M., Engl W., Maritsch F., Rosen F.S., Eder G., Zerlauth G., et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 38 (1998) 540-549
15. Hack C.E. C1-inhibitor: antigenic and functional analysis. Methods Mol Biol 150 (2000) 159-172
16. Teitel J.M., Bauer K.A., Lau H.K., and Rosenberg R.D. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex. Blood 59 (1982) 1086-1097
17. Farkas H., Harmat G., Fust G., Varga L., and Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 13 (2002) 153-161
18. Cicardi M., Mannucci P.M., Castelli R., Rumi M.G., and Agostoni A. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 35 (1995) 209-212